A temporary cessation of infectious disease testing services at the Centers for Disease Control and Prevention (CDC) has ignited a…
Read More
Hydrogen Sulfide and CSE Protein Research Offers New Therapeutic Target for Alzheimer’s Disease Treatment and Brain Health
Researchers at Johns Hopkins Medicine have announced that a newly funded study by the National Institutes of Health (NIH) is…
Read More
Internal Cellular "Trade Winds" Discovered, Revolutionizing Understanding of Cell Movement and Disease
Researchers at Oregon Health & Science University (OHSU) have unveiled a groundbreaking discovery: a previously unrecognized internal cellular system that…
Read More
Lifelong Cognitive Enrichment Linked to Significant Delay in Alzheimer’s Disease and Cognitive Decline
Engaging in mentally stimulating activities across a person’s entire lifespan—ranging from childhood reading habits to learning new languages and playing…
Read More
Breath-Based VOC Analysis Emerges as a Rapid, Non-Invasive Frontier for Gut Microbiome Assessment and Early Disease Detection
A groundbreaking study led by researchers from Washington University School of Medicine and Children’s Hospital of Philadelphia has identified a…
Read More
A Single Prenatal Toxic Exposure Linked to Multi-Generational Disease Risk, Paving Way for Epigenetic Diagnostics
New research emerging from Washington State University (WSU) has unveiled a groundbreaking understanding of disease inheritance, suggesting that a singular…
Read More
Brain Immune Response Linked to Early Loss of Smell in Alzheimer’s Disease Patients
The loss of the sense of smell, or anosmia, has long been documented as one of the most frequent and…
Read More
Paternal Age and Genetic Risk: New Research Reveals How Natural Selection Within Sperm Favors Disease-Causing Mutations
A groundbreaking pair of studies published on October 8 in the journal Nature has fundamentally altered the scientific understanding of…
Read More
FDA Proposes Permanent Authorization of Rare Pediatric Disease Priority Review Voucher Program to Foster Regulatory Stability
The United States Food and Drug Administration (FDA) is making a significant move to permanently authorize the rare pediatric disease…
Read More
Everest Medicines Acquires Hasten Biopharmaceuticals for $250 Million to Bolster Asia Pacific Chronic Disease Portfolio and Commercial Reach
Everest Medicines, a leading biopharmaceutical company focused on developing and commercializing innovative medicines for chronic diseases, has announced a significant…
Read MoreYOU MAY HAVE MISSED
